Skip to content

Effect of Holy Basil on Subjects With Sensitive Skin

OBSERVATIONAL STUDY OF THE EFFICACY ON SENSITIVE SKIN OF AN ORAL FORMULATION BASED ON PURPLE BASIL, FOR 8 WEEKS IN 2 GROUPS OF 100 VOLUNTEERS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07811310
Enrollment
200
Registered
2026-09-10
Start date
2026-08-31
Completion date
2026-11-18
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensitive Skin Related to Stress

Brief summary

Stress can have multiple and varied psychological and clinical impacts on skin diseases (Colavincenzo and Granstein, 2006; Graubard et al., 2021). In particular, psychological stress has been shown to reduce the rebuilding kinetics of the skin barrier when altered and it is suggested that psychological stress may trigger or exacerbate immune-mediated dermatological disorders (Hall et al., 2012). Certain symptoms related to sensitive skin problems (itching, burning, pain, etc.) can lead to sleep disorders associated with stress and anxiety. Conversely, these sleep disorders and anxiety or stress due to external sources are known to promote the appearance of symptoms related to skin sensitivity in patients who are at risk of developing sensitive skin syndrome (Farage, 2022). Expanscience Laboratories, manufacturer of cosmetics and dietary supplements, has identified a HOLY BASIL plant extract as a solution to address the negative impacts of stress on sensitive skin symptoms. The main goal of this double blinded randomized controlled clinical study is to evaluate in vivo the effect of an active ingredient HOLY BASIL incorporated into a food supplement on sensitive skin symptoms related to psychological stress after 28 and 56 consecutive days of a twice-daily intake, in comparison with the baseline and a placebo. Evaluation of the effectiveness of HOLY BASIL will be evaluated using psychometric questionnaires related to stress, sensitive skin and overall perception.

Interventions

DIETARY_SUPPLEMENTHoly basil extract

2 pills per day

DIETARY_SUPPLEMENTPlacebo

2 pills per day

Sponsors

Laboratoires Expanscience S.A.
Lead SponsorINDUSTRY
Dermaclaim Lab S.L.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Gender: Women * People aged between 45 and 65 years. * Presenting sensitive skin (Sensitive Scale 10 ≥ 20) with Tightness ≥ 4 and general malaise ≥ 4. * People who report being stressed (PSS10 questionnaire ≥ 14) and who report a relationship between skin sensitivity and psychological stress (according to the volunteer's opinion). * Last participation in a clinical study on the face, which ended at least 8 weeks before the start of this study. * Washing phase of 15 days without application of products on the face, or oral intake.

Exclusion criteria

* People with gastrointestinal diseases (diabetes, gastritis, Crohn's disease, celiac disease, ulcers, intolerances, etc.). * People with allergies to 'purple basil' or its excipients (maltodextrin, magnesium stearate). * Have other physiological disorders (diabetes, hypertension, dyslipidemia) and/or gallstones. * Individuals under medical treatment in the weeks prior to the study, which may interfere with the evaluations of the present study. * People who are pregnant or intend to be pregnant within the study period, as well as people who are breastfeeding. * People who are within a dietary period outside of their usual habit, or intend to change their eating routine during the study period. * People participating in another clinical study with similar characteristics (according to the investigator's criteria), during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Sensitive skin symptomsAt baseline and after 28 days and 56 daysEvaluation using Sensitive Scale-10 (SS-10) questionnaire

Secondary

MeasureTime frameDescription
Perceived stressAt baseline and after 28 days and 56 daysEvaluation using PSS-10 questionnaire
Self perceptionAfter 28 days and 56 daysAssessment using self assessment questionnaire

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026